Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 32

Trial Status

Completed2
Other1

Role Distribution

Principal Investigator2
Other Roles1
PI Rate67%

Activity Timeline

Clinical Trials (3)

NCT00003100Not ApplicableUnknown
Dietary Soy Isoflavones for the Prevention of Cancer
Unspecified Adult Solid Tumor, Protocol Specific
Studychair
NCT00007020Phase 3Completed
Compassionate Treatment of Patients With Inborn Errors of Bile Acid Metabolism With Cholic Acid
AdrenoleukodystrophyCholestasisInfantile Refsum's Disease+2 more
Principalinvestigator

Research Network

Collaboration Network

3 collaborators·2 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

James Heubi, MD

Children's Hospital Medical Center, Cincinnati

Similar
1 trials

Shared therapeutic areas:

AdrenoleukodystrophyCholestasisRefsum Disease, Infantile+2 more

Worked with same sponsors:

Children's Hospital Medical Center, CincinnatiMirum Pharmaceuticals, Inc.
Collaborated on 1 trial
Similarity Score54%

James E Heubi, MD

Children's Hospital Medical Center, Cincinnati

Related
2 trials

Shared therapeutic areas:

Bile Acid Synthesis Defect

Worked with same sponsors:

Mirum Pharmaceuticals, Inc.
Collaborated on 1 trial
Similarity Score14%

Ingrid Mayer, MD

Vanderbilt-Ingram Cancer Center

Related
13 trials

Shared therapeutic areas:

Unspecified Adult Solid Tumor, Protocol Specific

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Heinz-Josef Lenz, MD

University of Southern California

Related
13 trials

Shared therapeutic areas:

Unspecified Adult Solid Tumor, Protocol Specific

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Scot C. Remick, MD

Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center

Related
13 trials

Shared therapeutic areas:

Unspecified Adult Solid Tumor, Protocol Specific

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Corey J. Langer, MD

Fox Chase Cancer Center

Related
16 trials

Shared therapeutic areas:

Unspecified Adult Solid Tumor, Protocol Specific

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Gustavo Leone

Medical University of South Carolina, Hollings Cancer Center

Related
12 trials

Shared therapeutic areas:

Unspecified Adult Solid Tumor, Protocol Specific
Similarity Score4%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

Unspecified Adult Solid Tumor, Protocol Specific

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Averell Sherker, MD

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Related
11 trials

Shared therapeutic areas:

Cholestasis
Similarity Score4%

William I. Bensinger, MD

Fred Hutchinson Cancer Center

Related
12 trials

Shared therapeutic areas:

Unspecified Adult Solid Tumor, Protocol Specific

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT00003100Not ApplicableStudyChair

Dietary Soy Isoflavones for the Prevention of Cancer

Unspecified Adult Solid Tumor, Protocol Specific
Unknown
NCT00007020Phase 3PrincipalInvestigator

Compassionate Treatment of Patients With Inborn Errors of Bile Acid Metabolism With Cholic Acid

AdrenoleukodystrophyCholestasisInfantile Refsum's Disease+2 more
Completed
NCT01438411Phase 3PrincipalInvestigator

Open Label, Continuation Study of Cholic Acid in Subjects With Inborn Errors of Bile Acid Synthesis

Bile Acid Synthesis Defect
Completed

All 3 trials loaded